ArticleFrontiers in immunology2018

Relapsing-Remitting Multiple Sclerosis Is Characterized by a T Follicular Cell Pro-Inflammatory Shift, Reverted by Dimethyl Fumarate Treatment.

Vanesa Cunill et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.